InvestorsHub Logo
Post# of 251868
Next 10
Followers 23
Posts 2525
Boards Moderated 0
Alias Born 10/26/2003

Re: 10nisman post# 927

Wednesday, 01/21/2004 7:54:34 PM

Wednesday, January 21, 2004 7:54:34 PM

Post# of 251868
Re: Obesity article fr om CNN.com.......
by: wealthyworker (36/M/Chicago, IL)
Long-Term Sentiment: Strong Buy 01/21/04 07:27 pm
Msg: 39127 of 39129

GENR's HIDDEN GEM:

Obesity Therapeutic Program

Trodulamine (MSI-1436) is another natural aminosterol product candidate. Our scientists have demonstrated the ability to reduce the weight of genetically altered mice, generally very obese mice about 10 times their normal size, to that of a normal healthy mouse. Body weights of healthy animals, including animals with diet-induced obesity, also have been reduced through the administration of trodulamine. Our researchers have shown preclinical efficacy with trodulamine, and demonstrated that animal food intake can be regulated in a reversible manner, leading to changes in body weight. Preclinical data on trodulamine demonstrate it is a potent appetite suppressant with the ability to normalize fasting blood sugar, as well as high blood cholesterol levels, resulting from weight loss in obese animals. With trodulamine, we are targeting the approximately 10 to 12 million Americans who are classified medically as significantly obese. While the trodulamine molecule is very different in function, it has a similar chemical structure to squalamine, and thus would enable us to make more efficient use of internal and external resources already utilized for squalamine in its development. Preclinical results with trodulamine suggest that additional work on formulation and delivery of this compound in a safer and more convenient fashion would be the next milestones for development, if a business partnership or program-specific funding can be obtained. Further preclinical development work will be needed before an Investigational New Drug application can be filed with the FDA. Due to the limitations of our current resources, we do not intend to actively pursue the development of this product candidate at this time but we continue to seek new opportunities that will enable us to capitalize on our past development efforts in this program.


DEW - HOW LONG DO YOU THINK IT'LL TAKE GENR TO START DEVELOPING MSI-1436 AFTER SQUALAMINE IS ALL PARTNERED UP?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.